儿科的水脑
Kristopher T Kahle1,2,3, Petra M Klinge4, Jenna E Koschnitzky5
1Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. kahle.kristopher@mgh.harvard.edu.
Nature reviews. Disease primers
|May 16, 2024
概括
水脑,脑脊液 (CSF) 失衡,导致心室扩张. 基因组学和成像学的进步为精确的预后和这种疾病的非手术治疗提供了新的希望.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 遗传学 是一个遗传学.
背景情况:
- 水脑涉到脑脊液 (CSF) 不平衡,导致脑室扩张.
- 它表现为婴儿头部周长增加,老年儿童头部内压升高.
- 原因包括遗传突变 (先天性) 或中枢神经系统感染/出血 (获得).
研究的目的:
- 为水头提供全面的概述,包括其病理生理学,临床表现和当前的管理策略.
- 突出最近技术进步对理解和治疗水脑的影响.
- 探索水脑研究和治疗开发的不断变化的景观.
主要方法:
- 综述现有关于水头病理生理学,诊断和治疗的文献.
- 分析不同年龄组的临床表现.
- 讨论遗传因素,神经成像和新兴技术.
主要成果:
- 水脑症的特点是中断的CSF平衡和心室扩大.
- 临床表现因年龄而异,从头周长增加到内压力升高的迹象.
- 目前的治疗方法包括手术切除CSF或内镜手术,胎儿病例可以选择在子宫内.
结论:
- 长期结果受遗传和环境因素的影响.
- 基因组学,先进的大脑成像和其他技术对于完善诊断,改善预后和识别新型非手术治疗至关重要.
- 持续的研究对于推进水头治疗和改善患者的治疗结果至关重要.
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...


